missing translation for 'onlineSavingsMsg'
Learn More

(E/Z)-Zotiraciclib, MedChemExpress

Product Code. 16468927
Encompass_Preferred
Change view
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
5mg
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16468927 5 mg 5mg
16432457 50 mg 50mg
16416656 100 mg 100mg
16406348 10 mg 10mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
This item is not returnable. View return policy
Product Code. 16468927 Supplier Medchem Express Supplier No. HY15166

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress (E/Z)-Zotiraciclib ((E/Z)-TG02) is a potent inhibitor of CDK2, JAK2, and FLT3. (E/Z)-Zotiraciclib ((E/Z)-TG02) can be used for the research of cancer.

(E/Z)-Zotiraciclib ((E/Z)-TG02) is a potent inhibitor of CDK2, JAK2, and FLT3. (E/Z)-Zotiraciclib ((E/Z)-TG02) can be used for the research of cancer.

Specifications

Chemical Name or Material (E/Z)-Zotiraciclib
CAS 937270-47-8
Color Off-White
Purity Grade Notes Research
Molecular Formula C23H24N4O
Quantity 5 mg
Synonym (E/Z)-TG02 (E/Z)-SB1317
Solubility Information DMSO : 26.5 mg/mL (71.15 mM; Need ultrasonic and warming)
SMILES CN1CC2=CC(NC3=NC(C4=CC(OCC/C=C/C1)=CC=C4)=CC=N3)=CC=C2
Molecular Weight (g/mol) 372.46
Formula Weight 372.46
Percent Purity 98.09%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.